Last updated on January 2019

A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer


Brief description of study

This is an international multi-center, prospective, open-label, randomized, adaptive design phase 3 trial of the cancer stem cell pathway inhibitor napabucasin plus standard bi-weekly FOLFIRI versus standard bi-weekly FOLFIRI in patients with previously treated metastatic colorectal cancer (CRC).

Clinical Study Identifier: NCT02753127

Contact Investigators or Research Sites near you

Start Over

Alabama Oncology

Birmingham, AL United States
  Connect »

Mayo Clinic Arizona

Phoenix, AZ United States
  Connect »

St. Joseph Heritage Healthcare

Santa Rosa, CA United States
  Connect »

Sarah Cannon Research Institution

Saint Petersburg, FL United States
  Connect »

Palm Beach Cancer Institute

West Palm Beach, FL United States
  Connect »

Illinois Cancer Specialists

Arlington Heights, IL United States
  Connect »

Parkview Research Center

Fort Wayne, IN United States
  Connect »

Cancer Center of Kansas

Wichita, KS United States
  Connect »

Dana Farber

Boston, MA United States
  Connect »

Umass Memorial Medical Center

Worcester, MA United States
  Connect »

Mayo Clinic Arizona

Rochester, MN United States
  Connect »

Research Medical Center

Kansas City, MO United States
  Connect »

Tennessee Oncology PLLC

Omaha, NE United States
  Connect »

Carol G. Simon Cancer Center

Morristown, NJ United States
  Connect »

University of New Mexico

Albuquerque, NM United States
  Connect »

Roswell Park Cancer Center

Buffalo, NY United States
  Connect »

Wake Forest Baptist Medical Center

Winston-Salem, NC United States
  Connect »

Geisinger Medical Center

Danville, PA United States
  Connect »

VA Pittsburgh Healthcare System

Pittsburgh, PA United States
  Connect »

Sanford Cancer Center

Sioux Falls, SD United States
  Connect »

West Cancer Center

Memphis, TN United States
  Connect »

Texas Oncology - Fort Worth

Fort Worth, TX United States
  Connect »

Millenium Oncology

Houston, TX United States
  Connect »

Texas Oncology-San Antonio

San Antonio, TX United States
  Connect »

Texas Oncology - Tyler

Tyler, TX United States
  Connect »

Northern Utah Associates

Ogden, UT United States
  Connect »

Fort Belvoir Community Hospital

Fort Belvoir, VA United States
  Connect »

Blue Ridge Cancer Care

Roanoke, VA United States
  Connect »

Virginia Mason

Seattle, WA United States
  Connect »

St Vincent's Hospital

Darlinghurst, Australia
  Connect »

Flinders Medical Centre

Bedford Park, Australia
  Connect »

Bendigo Hospital

Bendigo, Australia
  Connect »

Austin Hospital

Heidelberg, Australia
  Connect »

Western Health

Melbourne, Australia
  Connect »

H pital Erasme

Bruxelles, Belgium
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Irccs Irst

Meldola, Italy
  Connect »

CHU Estaing

Clermont Ferrand, France
  Connect »

Centre Rene Gauducheau

Saint-Herblain, France
  Connect »

FN Hradec Kralove

Hradec Králové, Czechia
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.